Clinical Trials Logo

Filter by:
NCT ID: NCT04764110 Completed - Joint Pain Clinical Trials

Short-term Impact of Cyplexinol® on Self-reported Joint Pain

Start date: March 17, 2021
Phase: N/A
Study type: Interventional

In this study, the impact of 900 mg Cyplexinol® taken daily on joint pain over a period of 15 days in comparison with a placebo will be determined using a cross-over double blind design with a 13 day wash out period. In addition, we will measure cytokine production and related variables during the two hour after subjects ingest a single dosage of Cyplexinol® or placebo on days 1 and 15.

NCT ID: NCT04763980 Completed - Prostate Carcinoma Clinical Trials

Community-Based Health Coach to Improve Access to Germline Genetic Testing Among African American Men With Prostate Cancer

Start date: January 15, 2021
Phase: N/A
Study type: Interventional

This clinical trial studies barriers to genetic testing in African American men with prostate cancer and whether tailored, culturally relevant genetic testing education provided by a community-based health coach is beneficial in improving knowledge, attitudes, and awareness of genetic testing. Information gained from this study, may help researchers better understand and learn more about how to increase access to germline genetic testing in underrepresented populations.

NCT ID: NCT04763902 Completed - Clinical trials for Endometrial Neoplasms

Time Restricted Eating (TRE) Among Native Hawaiian/Pacific Islander Women at Risk for Endometrial Cancer

TIMESPAN
Start date: February 18, 2021
Phase: N/A
Study type: Interventional

The long-term goal of this study is to determine the efficacy of time restricted eating (TRE) for improving metabolic health and preventing endometrial cancer. The primary objective of the protocol is to conduct a 14-week two-arm randomized crossover trial of a dietary intervention to evaluate the feasibility, fidelity and preliminary acceptability of a TRE intervention among Native Hawaiian/Pacific Islander women at risk for developing endometrial cancer, and to provide proof of principle that TRE can improve metabolic health in this population.

NCT ID: NCT04763876 Completed - Analgesia Clinical Trials

Intramuscular Ketorolac at Two Single-Dose Regimens

Start date: June 27, 2020
Phase: Phase 4
Study type: Interventional

The purpose of this study was to evaluate a single 15 mg intramuscular (IM) dose of ketorolac for analgesic non-inferiority versus a single 60 mg IM dose for the treatment of acute MSK pain in a military emergency department (ED) that services Department of Defense (DoD), Department of Veteran Affairs (VA), and foreign military beneficiaries

NCT ID: NCT04763824 Completed - Breast Cancer Clinical Trials

KanSurvive: Testing a Model for Improving Cancer Survivorship Care in Rural Practice

KANSURVIVE
Start date: November 18, 2020
Phase: N/A
Study type: Interventional

Approximately, 20 rural primary care practices to participate in a delayed intervention-controlled trial. Phase I: Formal and structured work flow evaluations to better identify specific gaps in processes of care while assessing what on-going training is needed for adoption of high-quality cancer survivorship care in rural practice. These will be incorporated into the ECHO sessions (Aim 1). Phase II: Conduct and test the effectiveness of the novel KanSurvive-ECHO intervention (Aim 2) and finally identify barriers and facilitators to implementation of KanSurvive-ECHO (Aim 3).

NCT ID: NCT04763759 Completed - Clinical trials for Prosthetic Joint Infection

Study to Evaluate Safety and Activity of TRL1068 in Prosthetic Joint Infections

Start date: February 8, 2021
Phase: Phase 1
Study type: Interventional

TRL1068 is expected to eliminate the pathogen-protecting biofilm in the prosthetic joint and surrounding tissue, thus making these pathogens substantially more susceptible to established antibiotic treatment regimens. This initial study is designed to assess overall safety and pharmacokinetics (PK) of TRL1068. The overall goal of the development program is to demonstrate that TRL1068 can facilitate effectiveness of a single stage joint replacement or preservation of the original infected prosthetic joint in a substantial proportion of patients with PJI.

NCT ID: NCT04763694 Completed - Myopia Clinical Trials

Dynamic Change in Accommodation After Wearing Multifocal Soft Contact Lenses for Myopia Control

Start date: October 1, 2018
Phase: N/A
Study type: Interventional

The purpose of this study is to report the changes in accommodation, aberrations, and myopia in patients wearing multifocal soft contact lens for various durations. The study objectives are to: 1. Determine the effects of wearing multifocal soft contact lens on accommodation and aberrations over a 12-month period. 2. Determine the effect of wearing multifocal soft contact lens on myopia over a 12-month period.

NCT ID: NCT04763590 Completed - Anxiety Clinical Trials

Cognitive Behavioral Therapy for Mechanical Ventilation Wean

Start date: November 29, 2017
Phase: N/A
Study type: Interventional

The purpose of this study is to use CBT strategies in assisting patients hospitalized in intensive care units in ventilation wean through a case series of 2 patients.

NCT ID: NCT04763564 Completed - Pouchitis Clinical Trials

Efficacy of Liraglutide Therapy in Patients With IPAA

Start date: March 22, 2022
Phase: Phase 2
Study type: Interventional

Patients with an ileal pouch-anal anastomosis(IPAA; pouch) due to refractory inflammatory bowel disease and increased bowel frequency in the absence of significant pouch inflammation will be randomized to liraglutide or placebo in a prospective cross over study.

NCT ID: NCT04763421 Completed - Clinical trials for Upper GI; Lower GI; Gynecological

A Prospective, Single-Arm Multi-Center Study of the ENSEAL X1 Curved Jaw Tissue Sealer in Select Procedures

Start date: April 22, 2021
Phase: N/A
Study type: Interventional

This prospective, single-arm, multi-center study will collect clinical data in a post-market setting by procedure group (upper gastrointestinal [GI], lower GI, and gynecological). Investigators will perform each procedure using the device in compliance with their standard surgical approach and the ENSEAL X1 Curved Jaw and Generator G11 instructions for use.